US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 483 actively recruiting studies with Ohio sites out of 483 registered in total. The busiest research areas in Ohio are Heart Failure, Advanced Solid Tumor, Atrial Fibrillation. Leading sponsors running trials in the state include The Cleveland Clinic, Children's Hospital Medical Center, Cincinnati, Ohio State University. By stage, Ohio trials break down as Phase 1 (68), Phase 2 (112), Phase 3 (114), Phase 4 (19).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
483
Recruiting Now
483
← Back to US Map
Top Conditions in Ohio
Heart Failure (10)Advanced Solid Tumor (6)Atrial Fibrillation (6)Parkinson Disease (5)Cardiovascular Diseases (5)Non-Small Cell Lung Cancer (5)Acute Myeloid Leukemia (5)Cancer (4)Stroke (4)Schizophrenia (4)Prostate Cancer (4)Malignant Solid Neoplasm (3)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 483 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 483. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Heart Failure, Advanced Solid Tumor, Atrial Fibrillation, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06008795 Phase 2
Recruiting
BLOCK-SAH - PPF-Block for Post-SAH Headache
Condition
Subarachnoid Hemorrhage, Aneurysmal
Enrollment
195 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT03665675 EARLY_Phase 1
Recruiting
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease ...
Condition
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Enrollment
20 pts
Location
United States
Sponsor
Sumithira Vasu
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT05929677 EARLY_Phase 1
Recruiting
Impulsivity Domains and Subjective Response
Condition
Alcohol Use Disorder
Enrollment
250 pts
Location
United States
Sponsor
Jessica Weafer
View Trial →
NCT06057051 N/A
Recruiting
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to...
Condition
Glaucoma
Enrollment
245 pts
Location
United States
Sponsor
Glaukos Corporation
View Trial →
NCT07231705 N/A
Recruiting
Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Mont...
Condition
Formula Dependent Children 1 to 2 Years of Age
Enrollment
40 pts
Location
United States
Sponsor
Kate Farms Inc
View Trial →
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT07250802 Phase 3
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Condition
Plaque Psoriasis
Enrollment
110 pts
Location
United States, China, Germany
Sponsor
Takeda
View Trial →
NCT05591066 N/A
Recruiting
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety...
Condition
Communication
Enrollment
14,400 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT05172245 Phase 1
Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
46 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07647354 N/A
Recruiting
Mako-MORE Registry
Condition
Arthropathy of Knee
Enrollment
950 pts
Location
United States
Sponsor
Stryker Orthopaedics
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07743580 Phase 3
Recruiting
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) ...
Condition
SARS-CoV-2
Enrollment
2,000 pts
Location
United States, Bulgaria, Japan
Sponsor
Shionogi
View Trial →
NCT06461897 Phase 3
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral U...
Condition
Atopic Dermatitis
Enrollment
675 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT07711418 Phase 3
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age W...
Condition
Moderate-to-Severe Atopic Dermatitis
Enrollment
510 pts
Location
United States
Sponsor
Nektar Therapeutics
View Trial →
NCT03850574 Phase 1, Phase 2
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharma...
Condition
Leukemia, Myeloid, Acute
Enrollment
240 pts
Location
United States, Australia, Germany
Sponsor
Aptose Biosciences Inc.
View Trial →
NCT06827990 N/A
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissection...
Condition
Aortic Dissection
Enrollment
112 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT07225491 N/A
Recruiting
Spine Oncology Registry
Condition
Spine Tumor
Enrollment
3,000 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT05001880 Phase 2
Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Condition
Peritoneal Malignant Mesothelioma
Enrollment
66 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05549297 Phase 3
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced ...
Condition
Advanced Melanoma
Enrollment
540 pts
Location
United States, Australia, Austria
Sponsor
Immunocore Ltd
View Trial →
NCT07562997 N/A
Recruiting
Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm ...
Condition
Very Preterm and Extremely Preterm Birth
Enrollment
150 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT01656603 Phase 2
Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cor...
Condition
Infusion Reactions
Enrollment
9,999 pts
Location
United States
Sponsor
New York Blood Center
View Trial →
NCT07036523 Phase 2
Recruiting
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People W...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
71 pts
Location
United States, Australia, Belgium
Sponsor
Boehringer Ingelheim
View Trial →
NCT07291479 N/A
Recruiting
Behavioral Assessment Method Index
Condition
Infant Development
Enrollment
80 pts
Location
United States
Sponsor
Ohio State University
View Trial →
Page 5 of 20 — 483 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology